slidedeck.co

Theranos investor presentation, Partnership meeting 08.06.14

Cover slide of the Theranos 2014 investor presentation
Cover of Theranos' 2014 investor presentation.

This confidential internal partnership meeting deck, dated 6 August 2014, was prepared by Theranos for its retail pharmacy partner Walgreens. It opens with a title slide and a numbered agenda covering kick-off, current status, anchored values, success measures, the FY15 plan, California plans and standard testing. The status section presents store counts, launch waves and visit-time medians as plain bullets. A survey summary follows, with a headline stat slide, star-rating bar charts and pie charts for prescription sources and likelihood to return. Next comes a quote slide of patient comments, then tables of shortest and longest visit times by store. The opportunities section lists operational priorities, and a technician certification slide sets removal and reinstatement criteria. The Walgreens-branded middle section includes a business and change considerations matrix, a stakeholder model and a SMART goals table with owners and targets. The closing sections cover the FY15 market plan, a California T-minus schedule with a timeline graphic, and an IT phase plan with its scope. The deck ends with its phase 3 priorities.

Slides worth studying

  • Slide 5: Small multiple bar charts with consistent axes and a single highlighted average give the survey results a clear, scannable form.
  • Slide 36: A Gantt-style timeline lays out parallel workstreams across months with dated milestones, making a complex rollout readable at a glance.
  • Slide 21: Three anchor words sit in a simple triangular arrangement with a short framing question, a restrained way to present a core message.

Questions about this deck

How many slides does the Theranos partnership meeting deck have?

The Theranos partnership meeting deck, dated 6 August 2014, is listed as having 39 pages. Slide 1 is the title slide, which opens the deck.

What does the Theranos deck say about current store status and median check-in time?

Slide 3 states that 30 stores are currently live (AZ 29; CA 1) and that the median check-in time is 5 min, a decrease of 1 min. The same slide reports total visits in August of 2637.

What does the Theranos survey summary report for overall experience?

Slide 4 reports 650 unique respondents for the period July 2 to August 4, 2014, with an average overall experience score of 4.85 stars. Slide 5 shows the bar chart for this overall experience rating.

What success criteria does the Theranos SMART goals slide list for patient experience?

Slide 27 lists a likelihood to come back of 90% or more by 8/31/15 and a referral by a friend or family member of 20% or more by 8/31/15. The same slide sets a training pass rate of 90% or more by 8/31/15.

Details

More from Theranos

All Theranos decks in the library

Review score: 4 out of 10, Ineffective

Presentation quality, judged with the SlideDeck Co review heuristic. Ask, evidence and idea merit are not rated here.

The deck is a working-meeting artifact stitched from two organizations' templates, and the audience cannot follow a single argument through it. Many pages are repeated agenda trackers (slides 15, 16, 19, 24), several are dense tables set in tiny type that cannot be read at presentation size (slides 18, 22, 23), and slides 38 and 39 show clipped or empty-looking layouts. The survey charts on slide 5 and the timeline on slide 36 are legible and carry their point, but they sit among many slides with weak hierarchy, no takeaway titles and unexplained content such as the Venn on slide 21.

Worth keeping: Keep the survey bar charts on slide 5 with their direct value labels and average per chart, and the color-coded workstream bars of the timeline on slide 36.

Most useful repair: Cut the repeated change-management tracker slides, enlarge or split the stakeholder and matrix tables on slides 17, 18, 22 and 23, and fix the overlapping footers and the clipped table on slide 38.

What would change the score: I would rebuild the deck as one template with action titles that state each page's conclusion, so a reader gets a clear status, decisions needed and next steps without a presenter.

Confidence high. 39 of 39 pages inspected on contact sheets, 4 at readable size. Reviewed 2026-11-09. Model-assisted review (claude-sonnet-5-5).

Full text of the slides (39 slides)

Every slide's words and a description of its charts and images, so the deck can be searched and rebuilt. Also available as Markdown.

Slide 1

theranos

partnership meeting

08.06.14

this presentation and its contents are theranos property and confidential.

Trial Exh. 1884 Page 0017

1

Visuals: One logo: the theranos wordmark, about 33.5% wide by 11.0% high, placed at x 63.3, y 44.0. The letters are a bold, rounded grey sans-serif (#636466). The 'o' is replaced by a glossy teal-green sphere, shaded from pale mint at the top (#BFEDE0) to deeper green at the bottom (#1AAA82). No photographs, charts, or other graphics.

Slide 2

agenda

kick-off/introductions

Sunny/Nimesh

current status

Sunny/Nimesh

discuss anchored values

Mike

Lewis

discuss program measures of success

Nimesh

(SMART goals)

plan for FY15

Casey

california plans

Sunny/Nimesh

std testing

Sunny/Pat Carroll

Trial Exh. 1884 Page 0018

theranos confidential

2

Visuals: Non-photographic. The only graphic is the theranos logo (raster image, 138 by 26 pixels) at bottom right, wordmark in dark grey with a teal-green dot in place of the letter o. Bullets are solid round dots (●) in grey #646569. No charts, tables, photographs or diagrams.

Slide 3

current status

Sunny

30 stores currently live (AZ 29; CA 1)

wave 4 launch dates – Aug 19 and Aug 26 – stores TBD

total visits in August – 2637

27 out of 30 stores on DSL; Wave 4 wiring complete

TIFT team performing 65% of oversight visits

mostly improved patient experience

median check in time = 5 min – decr 1 min

median wait time = 7 min – incr 1 min

median perform time = 5 min – decr 2 min

total visit time = 17 min – decr 2 min

Trial Exh. 1884 Page 0019

theranos confidential

3

Slide 4

Theranos Experience Survey Summary

for period July 2 – August 4, 2014

Unique Respondents

650

Average Quality/Experience Scores

Overall Experience:

4.85 stars

Check In Process:

4.61 stars

Locating Theranos:

4.79 stars

Facilities:

4.79 stars

Sample Collection Process:

4.86 stars

Skill of Technician:

4.90 stars

Theranos Confidential

Trial Exh. 1884 Page 0020

Visuals: None apart from the theranos wordmark logo at bottom right: dark grey lowercase letters 'theranos' with the 'o' replaced by a teal-green dot. It is a small raster image (104 by 19 pixels), not cropped, not boxed, with no overlay.

Slide 5

Overall Experience

Check In Process

Locating Theranos

Facilities

600

500

400

300

200

100

0

1 4 4 6 47 556

600

500

400

300

200

100

0

0 1 2 3 4 5

Average: 4.85 stars

600

500

400

300

200

100

0

1 11 13 41 81 497

600

500

400

300

200

100

0

0 1 2 3 4 5

Average: 4.61 stars

600

500

400

300

200

100

0

0 5 6 20 51 534

Locating Theranos

0 1 2 3 4 5

Average: 4.79 stars

200

180

160

140

120

100

80

60

40

20

0

0 2 2 5 25 194

Facilities

0 1 2 3 4 5

Average: 4.79 stars

Theranos Confidential

Trial Exh. 1884 Page 0021

theranos

Visuals: Four vertical bar charts, each with 6 bars for star ratings 0 to 5 (x-axis label values 0,1,2,3,4,5; no axis titles, no units shown beyond stars in the averages). Y-axis gridlines light grey. Bars solid cyan blue #00A8E1 with no outlines; each bar carries a bold black value label above it. Chart 1 Overall Experience: y-axis 0 to 600 in steps of 100; values 0:1, 1:4, 2:4, 3:6, 4:47, 5:556; average 4.85 stars. Chart 2 Check In Process: y-axis 0 to 600 in steps of 100; values 0:1, 1:11, 2:13, 3:41, 4:81, 5:497; average 4.61 stars. Chart 3 Locating Theranos: y-axis 0 to 600 in steps of 100; values 0:0, 1:5, 2:6, 3:20, 4:51, 5:534; average 4.79 stars. Chart 4 Facilities: y-axis 0 to 200 in steps of 20; values 0:0, 1:2, 2:2, 3:5, 4:25, 5:194; average 4.79 stars. No legend. No highlighted points beyond the 5-star bar, which is tallest in each chart. The theranos logo is a wordmark in dark grey with a green dot replacing the o, boxed by nothing.

Slide 6

Sample Collection Process

Skill of Technician

600

558

700

600

500

500

400

400

300

300

200

200

100

100

36

1

5

2

10

0

0

0

1

2

3

4

5

0

1

2

3

4

5

1 5 1 7 22 577

Average: 4.86 stars

Average: 4.90 stars

Theranos Confidential

Trial Exh. 1884 Page 0022

Visuals: Two vertical bar charts. Left chart titled 'Sample Collection Process': y-axis 0 to 600 in steps of 100 with gridlines; x-axis categories 0, 1, 2, 3, 4, 5 (star ratings). Values per bar: 0 = 1, 1 = 5, 2 = 2, 3 = 10, 4 = 36, 5 = 558 (value labels printed above each bar, bold). Right chart titled 'Skill of Technician': y-axis 0 to 700 in steps of 100 with gridlines; x-axis categories 0 to 5. Values: 0 = 1, 1 = 5, 2 = 1, 3 = 7, 4 = 22, 5 = 577 (value labels printed above each bar, bold). Bars are solid #00A8E1 with no outline; no legend; no highlighted points. Below each chart is a bold average line: 'Average: 4.86 stars' (left) and 'Average: 4.90 stars' (right). Small theranos logo at bottom right, a wordmark in dark grey with a teal-green dot in place of the o.

Slide 7

Where do you typically get your prescriptions filled?

Walgreens

7%

1%

3%

3%

CVS

7%

Walmart

Costco

12%

53%

Target

Safeway

15%

Rite-Aid

Other

Theranos Confidential

Trial Exh. 1884 Page 0023

Visuals: One pie chart with no title of its own, no axes and no legend box beyond the vertical list at right. Eight slices, clockwise from 12 o'clock: Walgreens 53% (#00B28C, green, largest slice, spanning from 12 o'clock around the right and bottom to about 8 o'clock); CVS 15% (#00A8E1, blue); Walmart 12% (#FFDD00, yellow); Costco 7% (#FF671B, orange); Target 3% (#E6E7E8, light grey); Safeway 3% (#A7A9AC, mid grey); Rite-Aid 1% (#C00000, dark red, thin sliver); Other 7% (#8CE1FF, light sky blue, ending at 12 o'clock). Percentage labels are printed in bold black Arial on each slice: 53%, 15%, 12%, 7% (Costco), 3% (Target), 3% (Safeway), 1% (Rite-Aid), 7% (Other); the 1%, 3% and 3% labels sit close together near the top-left edge of the small slices. Legend at right lists in order Walgreens, CVS, Walmart, Costco, Target, Safeway, Rite-Aid, Other, each with a small square swatch in the slice colour. Slices have thin white or hairline separators. The theranos logo is a raster image (104 by 19 pixels): dark grey wordmark 'theranos' with a teal-green dot replacing the 'o'.

Slide 8

Based on your recent visit, what is the likelihood that you will return to a

Theranos Wellness Center?

1%

17%

Definitely coming back

Likely to return

Not sure if I will return

82%

Theranos Confidential

Trial Exh. 1884 Page 0024

theranos

Visuals: Pie chart, no printed chart title beyond the slide headline. Three slices, clockwise from 12 o'clock: 'Definitely coming back' 82% (green slice, the largest, covering most of the right and bottom-left of the circle), 'Likely to return' 17% (blue slice, upper-left quadrant between about 10 and 12 o'clock), 'Not sure if I will return' 1% (thin yellow slice just left of 12 o'clock). Percent labels are printed in black bold sans-serif inside or near each slice: 1% near the yellow slice, 17% inside the blue slice, 82% inside the green slice near the lower-right edge. No axes. Legend on the right with square colour swatches: green swatch beside 'Definitely coming back', blue swatch beside 'Likely to return', yellow swatch beside 'Not sure if I will return', listed top to bottom with even spacing. No highlighted points. Slice boundaries are thin, same-hue or hairline edges. Logo: the theranos wordmark in dark grey lowercase sans-serif with a teal-green gradient dot replacing the 'o', at bottom-right, about 8.1% wide.

Slide 9

Here’s what people are saying…

“Absolutely love the new technology Theranos has for blood tests. I will definitely let all my family and friends know about

your company.”

“Another fabulous experience! I didn't feel any pain, the procedure was so quick, and Tiffany was a delight! Thank you for

making the process of giving blood so easy and pleasant.”

“Best visit I have ever had. Amazing people they take really amazing care of people.”

“For a person who has severe phobia of needles and blood this was a pleasant experience all around.”

“This was the easiest lab test blood draw I’ve done in my life!”

“Fantastic experience! I couldn't even feel my skin being pierced; it was so easy. Thank you for inventing this to help people!”

“Easy and convenient! Can't beat the price.”

“Great customer service was provided at the Walgreens location lab today!”

Theranos Confidential

Trial Exh. 1884 Page 0025

theranos

Visuals: none apart from the theranos wordmark logo at bottom right: a dark grey lowercase wordmark 'theranos' in a bold sans-serif with the letter 'o' replaced by a small teal-green (#3BB39A approx.) filled circle, placed at x 88.8, y 94.0, 8.1 by 2.6 percent, 104 by 19 pixels.

Slide 10

shortest visit times

Median

Checkin

Time

(mins)

Name

WAG11610

4

WAG1272

4

WAG3132

4

WAG3177

4

WAG3464

4

WAG5668

4

Name

Median Wait

Time (mins)

WAG13596

5

WAG3477

5

WAG6582

5

WAG11610

6

WAG1272

6

WAG3132

6

WAG3657

6

WAG4188

6

WAG4508

6

WAG6060

6

Name

Median

Perform

Time (mins)

WAG13596

1

WAG3008

2

WAG3048

3

WAG5453

4

WAG2851

5

WAG3049

5

WAG3464

5

Trial Exh. 1884 Page 0026

theranos confidential

10

Visuals: No charts, photographs or illustrations. Three plain tables: Table 1 has columns Name and Median Checkin Time (mins) with 6 rows: WAG11610 4, WAG1272 4, WAG3132 4, WAG3177 4, WAG3464 4, WAG5668 4. Table 2 has columns Name and Median Wait Time (mins) with 11 rows: WAG13596 5, WAG3477 5, WAG6582 5, WAG11610 6, WAG1272 6, WAG3132 6, WAG3657 6, WAG4188 6, WAG4508 6, WAG6060 6. Table 3 has columns Name and Median Perform Time (mins) with 7 rows: WAG13596 1, WAG3008 2, WAG3048 3, WAG5453 4, WAG2851 5, WAG3049 5, WAG3464 5. Each table has a light grey horizontal rule under its header. One logo: the theranos wordmark in dark grey with a teal green dot in place of the o.

Slide 11

longest visit times / Name / Median Checkin Time (mins) / WAG2851 / 7 / WAG3008 / 7 / WAG4793 / 7 / WAG6060 / 7 / WAG6128 / 7 / WAG6697 / 7 / WAG1076 / 8 / WAG4188 / 8 / WAG4508 / 9 / WAG6582 / 9 / Name / Median Wait Time (mins) / WAG3048 / 8 / WAG3049 / 8 / WAG3177 / 8 / WAG3464 / 8 / WAG3912 / 8 / WAG6128 / 8 / WAG4793 / 9 / WAG3008 / 10 / WAG1076 / 12 / WAG6697 / 20 / Name / Median Perform Time (mins) / WAG6128 / 8 / WAG3912 / 9 / WAG5222 / 9 / WAG5504 / 9.5 / WAG4508 / 10 / WAG4793 / 10 / WAG6697 / 12 / Trial Exh. 1884 Page 0027 / theranos confidential / 11

Visuals: Three plain tables with no fills, no cell borders except a thin grey rule under each header row. Table 1 has columns Name and Median Checkin Time (mins) with rows WAG2851 7, WAG3008 7, WAG4793 7, WAG6060 7, WAG6128 7, WAG6697 7, WAG1076 8, WAG4188 8, WAG4508 9, WAG6582 9. Table 2 has columns Name and Median Wait Time (mins) with rows WAG3048 8, WAG3049 8, WAG3177 8, WAG3464 8, WAG3912 8, WAG6128 8, WAG4793 9, WAG3008 10, WAG1076 12, WAG6697 20. Table 3 has columns Name and Median Perform Time (mins) with rows WAG6128 8, WAG3912 9, WAG5222 9, WAG5504 9.5, WAG4508 10, WAG4793 10, WAG6697 12. Numeric values are right-aligned within their column. Row spacing is roughly 4.5% of slide height in the first table and slightly irregular in the others. One theranos wordmark logo at bottom right, dark grey lettering with a teal-green dot replacing the letter o, 138 by 26 px.

Slide 12

opportunities / Sunny / ● scalable strategy for check in / ● store by store – start with stores with 10+ patients per day / ● must start in August - will be tested during flu season / ● tight integration between HCC and Theranos check-in / ● call center knowledge of Theranos and communication to patients / ● assurance that 40% of stores will be dedicated space / ● improved staffing in all stores – surprises with Theranos tech shortages / ● need improvement in attentiveness of some stores / ● cleaning / ● attention to process – including opening and closing procedures / ● managing flow of patients / Trial Exh. 1884 Page 0028 / theranos confidential / 12 / theranos

Visuals: None apart from the corner logo: a Theranos wordmark at bottom right (x 86.7%, y 93.9%, 10.8% by 3.6% of the slide, 138 by 26 px). The word 'theranos' is set in a bold grey sans-serif, approximately #646569, with the letter 'o' replaced by a solid teal-green sphere, approximately #3BB39A, that sits on the baseline. The logo is unboxed and not cropped.

Slide 13

Certification Maintenance / 1. Criteria for removal of Certification / <80% fingerstick proficiency (Bi-Monthly) / Acting against established procedures (As reported) / 2. What happens next? / Technician becomes Check-In ONLY / Lead time to remove technician from live patient perform workflow (?) / 3. Reinstate Certification / Assess trainee using original oversight standards / At least 2 consecutive successful end-to-end visits / Idle Technicians / Technicians who perform <5 finger sticks in a given timeframe are required to complete / practice fingersticks / Trial Exh. 1884 Page 0029 / theranos confidential / 13 / theranos logo

Visuals: None apart from the theranos wordmark logo at bottom right: dark grey lettering reading 'theranos' in a bold sans-serif, with the letter o replaced by a glossy teal-green sphere (about #2BB59A) and a dark grey #5A5C5F wordmark; the logo is a raster image 138 by 26 pixels, unboxed and not cropped.

Slide 14

Diagnostic Testing – Theranos Partnership Change

Management Updates and Key Anchors Readout

• August 6, 2014

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

Trial Exh. 1884 Page 0030

Visuals: Logos only: (1) Walgreens red speech-bubble 'W' mark with a small trademark symbol, followed by the orange-and-grey 'CHANGE MANAGEMENT' wordmark with a stacked orange triangular stripe icon; (2) Walgreens red script wordmark over the tagline 'AT THE CORNER OF HAPPY & HEALTHY' in grey with green 'HAPPY' and blue 'HEALTHY'. The slide has no charts, photographs or diagrams; the rounded white panel and blue frame are background treatment.

Slide 15

Change Management Updates

• Change Management Updates

• Action Planning Exercise Results

• Key Anchors Discussion

• Readout from Discussion

• Next Steps

• Execute Against Change Management Action Planning Exercise Results

• Leveraging Key Anchors and Action Planning Exercise Results, Finalize FY15 Change

Strategy Draft

• Socialize FY15 Change Strategy

Trial Exh. 1884 Page 0031

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

15

Visuals: The only non-text visuals are the header band and the lower-left logo. The header is a flat, solid blue rectangle (image 1280 by 120 pixels) running full-bleed across the top 16.7% of the slide with no gradient, photograph or pattern. The logo is a red rounded square containing a white stylised 'w' mark with a small red tail at its lower-left, followed by a small orange chevron above the words 'CHANGE' and 'MANAGEMENT' in bold dark grey capitals stacked on two lines. No photographs, charts, tables or diagrams are present.

Slide 16

Change Management Updates

Change Management Updates

Action Planning Exercise Results

Key Anchors Discussion

Readout from Discussion

Next Steps

Execute Against Change Management Action Planning Exercise Results

Leveraging Key Anchors and Action Planning Exercise Results, Finalize FY15 Change Strategy Draft

Socialize FY15 Change Strategy

Trial Exh. 1884 Page 0032

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

16

CHANGE

MANAGEMENT

Visuals: Two logo images at the bottom left: a red rounded speech-bubble shape containing a white stylised script 'w' (Walgreens logo), and to its right a small orange-brown triangular mark followed by the words 'CHANGE MANAGEMENT' in dark grey bold sans-serif capitals on two lines. No charts, photographs or diagrams. The blue band is a flat rectangle with no gradient.

Slide 17

We Started Here: Business & Change Considerations Matrix Based on / Stakeholder Feedback

Recommended Focus Areas

Red = Short Term Recommended Actions

Purple = Both ST and LT Recommended Actions

Black = Long Term Recommended Actions

Definition of Success

Culture

Role Clarity

Business Readiness

Business Levers

Business Operations & Governance

• Clearly document decision rights & governance approach for partnership

• Further define short and long term success criteria

• Align business metrics to key behaviors

• Identify potential incentive alignment opportunities

• Reset “Pilot” vs. ““Initial Launch Market” expectations

• Identify common values shared by Walgreens and Theranos that can be leveraged to define success criteria

• Develop day to day interaction model that better pairs individuals across the partnership

• Define/align on Field, Corporate, and Theranos roles and responsibilities in the partnership

• Redefine/clarify roles for Kickoff Market vs. scale

• Further align governing bodies to decision making rights and escalation process

• Develop holistic Store Readiness checklist

• Define Pharmacy Workflow to incorporate scripts, WE, Theranos, and immunization services

• Develop pre-defined non-emergency SOP and app update calendar

• Define leading indicators to predict Program success

• Define scalable business model

Change Levers

Stakeholder Engagement, Communications, Organizational Alignment, and Training

• Align on communications strategy, plan, and execution with Theranos and field leadership

• Develop and measure additional training success criteria beyond pass rate

• Reframe “Pilot” vs. ““Initial Launch Market” language

• Develop and rally group behind both strategic and operational-level shared vision for the partnership

• Continue to incorporate Walgreens training principles, feedback and talent pool into training

• Leverage communications strategy recommendations (TBD)/agree on senders by message type

• Identify and develop district and store champions in existing and target markets

• Better align market/district leadership roles to training goals and focused value-add training activities

• Further enable TIFT team to realize team goals

• Facilitate SOP release approach alignment

• Identify best training practices and lessons learned from Kickoff Market to apply to scale

• Communicate Pharmacy Workflow to incorporate scripts, WE, Theranos, and immunization services

• Refine “T-minus” comms, Field Leadership Toolkit, and scenario planning exercises to better prepare field

• Measure business readiness based on lagging and leading indicators; recommend corrective actions

Trial Exh. 1884 Page 0033

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

17

Visuals: Table/matrix with 4 focus-area columns and 2 rows. Column headers (blue #56A0D3 cells): Definition of Success; Culture; Role Clarity; Business Readiness. Row 1 (Business Levers, light blue #D0DFEE): Definition of Success: Clearly document decision rights & governance approach for partnership (purple); Further define short and long term success criteria (black); Align business metrics to key behaviors (black); Identify potential incentive alignment opportunities (black). Culture: Reset “Pilot” vs. ““Initial Launch Market” expectations (red); Identify common values shared by Walgreens and Theranos that can be leveraged to define success criteria (purple); Develop day to day interaction model that better pairs individuals across the partnership (black). Role Clarity: Define/align on Field, Corporate, and Theranos roles and responsibilities in the partnership (red); Redefine/clarify roles for Kickoff Market vs. scale (black); Further align governing bodies to decision making rights and escalation process (black). Business Readiness: Develop holistic Store Readiness checklist (purple); Define Pharmacy Workflow to incorporate scripts, WE, Theranos, and immunization services (purple); Develop pre-defined non-emergency SOP and app update calendar (purple); Define leading indicators to predict Program success (black); Define scalable business model (black). Row 2 (Change Levers, pale #E9EFF7): Definition of Success: Align on communications strategy, plan, and execution with Theranos and field leadership (purple); Develop and measure additional training success criteria beyond pass rate (black). Culture: Reframe “Pilot” vs. ““Initial Launch Market” language (red); Develop and rally group behind both strategic and operational-level shared vision for the partnership (purple); Continue to incorporate Walgreens training principles, feedback and talent pool into training (purple). Role Clarity: Leverage communications strategy recommendations (TBD)/agree on senders by message type (red); Identify and develop district and store champions in existing and target markets (purple); Better align market/district leadership roles to training goals and focused value-add training activities (purple). Business Readiness: Further enable TIFT team to realize team goals (red); Facilitate SOP release approach alignment (purple); Identify best training practices and lessons learned from Kickoff Market to apply to scale (purple); Communicate Pharmacy Workflow to incorporate scripts, WE, Theranos, and immunization services (purple); Refine “T-minus” comms, Field Leadership Toolkit, and scenario planning exercises to better prepare field (purple); Measure business readiness based on lagging and leading indicators; recommend corrective actions (black). Colour key (legend, not a graphic): Red = Short Term Recommended Actions; Purple = Both ST and LT Recommended Actions; Black = Long Term Recommended Actions. Logo at bottom-left: the Walgreens red speech-bubble icon with a white stylised 'w' script, next to an orange chevron mark and the grey wordmark 'CHANGE MANAGEMENT' in two lines (CHANGE above MANAGEMENT). No photographs or illustrations.

Slide 18

We Discussed Each Consideration (and Agreed On An Action Plan for Each) Yesterday.

Example for “Definition of Success” Considerations Action Plan:

Business Levers

Recommended Action

Owner (of Next Steps)

Next Steps

Clearly document decision rights & governance approach for partnership

Patty, Mike, Casey

Christian

1) Discuss collaboration with Christian on 8/6

2) (Collaboratively) summarize Phoenix market approach, general partnership approach, and what future markets would look like

Further define short and long term success criteria

Tracy – to work at Store/Operational level

Casey, Mahesh, Mike (facilitate)

1) Follow up from 8/5 meeting key anchors discussion, 8/6 success criteria discussions

2) Tracy to document Theranos store/operational success criteria

Align business metrics to key behaviors

Mahesh, Mike

Leverage draft success criteria to align key behaviors/actions by role

Identify potential incentive alignment opportunities

Casey (working with workstream leads)

Theranos: future plan (past start-up mode)

Walgreens: Discuss potential approaches, timing with Casey

Change Levers

Recommended Action

Owner (of Next Steps)

Next Steps

Align on communications strategy, plan, and execution with Theranos and field leadership

Mike, Patty (to assist)

Document next iteration

Develop and measure additional training success criteria beyond pass rate

Mike, Ardith, John Look (to assist on reporting)

Joe, Ryan

Mike to set up brainstorming session with Joe, Ryan, Ardith, and John Look on possible success criteria

Trial Exh. 1884 Page 0034

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

1818

Visuals: Two tables, both pasted as images with a blue header row. Business Levers table (upper left, 759 by 317 px): columns Recommended Action, Owner (of Next Steps), Next Steps; rows: (1) Clearly document decision rights & governance approach for partnership (magenta text) | Patty, Mike, Casey / Christian | 1) Discuss collaboration with Christian on 8/6; 2) (Collaboratively) summarize Phoenix market approach, general partnership approach, and what future markets would look like; (2) Further define short and long term success criteria | Tracy – to work at Store/Operational level / Casey, Mahesh, Mike (facilitate) | 1) Follow up from 8/5 meeting key anchors discussion, 8/6 success criteria discussions; 2) Tracy to document Theranos store/operational success criteria; (3) Align business metrics to key behaviors | Mahesh, Mike | Leverage draft success criteria to align key behaviors/actions by role; (4) Identify potential incentive alignment opportunities | Casey (working with workstream leads) | Theranos: future plan (past start-up mode) / Walgreens: Discuss potential approaches, timing with Casey. Change Levers table (lower right, 896 by 264 px): columns Recommended Action, Owner (of Next Steps), Next Steps; rows: (1) Align on communications strategy, plan, and execution with Theranos and field leadership (magenta text) | Mike, Patty (to assist) | Document next iteration; (2) Develop and measure additional training success criteria beyond pass rate | Mike, Ardith, John Look (to assist on reporting) / Joe, Ryan | Mike to set up brainstorming session with Joe, Ryan, Ardith, and John Look on possible success criteria. The Walgreens CHANGE MANAGEMENT logo: a red rounded square with a white script W, beside an orange triangle and the dark grey wordmark CHANGE MANAGEMENT.

Slide 19

Change Management Updates

Change Management Updates

Action Planning Exercise Results

Key Anchors Discussion

Readout from Discussion

Next Steps

Execute Against Change Management Action Planning Exercise Results

Leveraging Key Anchors and Action Planning Exercise Results, Finalize FY15 Change Strategy Draft

Socialize FY15 Change Strategy

Trial Exh. 1884 Page 0035

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

19

Slide 20

Action Plan Next Steps

• Mike to Provide Full Action Plan Results to Group, Individuals Identified As / Owners (for All Four Focus Areas)

• Will Be Provided By End of Week

• Owners to Act Against Focus Areas

• Group to Identify Approach to Update Team

Trial Exh. 1884 Page 0036

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

20

Visuals: Non-text visuals: one flat blue header band (image, 1280 by 120 px, full width, top 16.7%, solid blue with no text or gradient) and one logo at bottom left (about 14.3% wide by 5.3% high). The logo shows a red rounded square containing a white stylised script 'W' (Walgreens mark) with a small red pointer at its lower left, followed by a small tan-orange chevron and the words CHANGE MANAGEMENT in bold dark grey sans-serif capitals stacked on two lines (CHANGE above MANAGEMENT). No charts, tables, photographs or diagrams.

Slide 21

Key Anchors Discussion / What could we ask a Pharmacy Technician to rally around, that is also meaningful to senior / leaders and others in our diverse stakeholder audience? / The common themes we agreed upon: / Pharmacy / Transformation / Patient Experience / [Scalable & Standardized] / Partnership / Relationship / Trial Exh. 1884 Page 0037 / ©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only. / 21

Visuals: Three overlapping ellipses forming a diagram. Left: a solid dark navy ellipse (#1E4164) at about x 11.1%, y 60.6%, w 24%, h 32%, containing the text 'Pharmacy / Transformation' in light blue. Centre: a larger ellipse at about x 31.7%, y 44.3%, w 33%, h 44%, filled navy #1E4164 at 60% opacity over a photographic network-of-nodes texture (thin connected lines and dot nodes in lighter blue-grey on blue facets), overlapping the left and right ellipses; it contains bold white 'Patient Experience' and white bold bracketed '[Scalable & Standardized]'. Right: an ellipse at about x 70%, y 43%, w 25%, h 34%, filled with a fine grey dot/hatch pattern (light grey on white), containing 'Partnership / Relationship' in navy text, which overlaps the centre ellipse's right edge. The logo is a red Walgreens 'W' mark in a speech-bubble shape with the grey 'CHANGE MANAGEMENT' wordmark featuring an orange triangle. No photographs apart from the network texture.

Slide 22

With These Anchors In Mind, We Discussed Some of the Behaviors and Actions We

Need to Ask of Our Stakeholders That Will Help the Program Realize Its Vision

Key Stakeholders like…

whose role is to…

…the Vision at the…

Should do/say/own

Brad Wasson

Rick Gates

Jeff Koziel

Nimesh Jhaveri

Elizabeth Holmes

Sunny Balwani

Define

Company level

Do:

Say:

Own:

Nimesh Jhaveri

Casey Kozlowski

Mahesh Raju

Sunny Balwani

Tracy Masson

Joe Ahdoot

Christian Holmes

Define

Program/ Partnership level

Do:

Say:

Own:

Matt Sesto

Brian Sizemore

Casey Kozlowski

Mahesh Raju

Tracy Masson

Kim Alfonso

Joe Ahdoot

Translate and reinforce

Kickoff Market level

Do:

Say:

Own:

DMs

RXSs

Sonia Cendejas

Operations Mgrs

Theranos Sales

Translate and reinforce

District level

Do:

Say:

Own:

CLs

TIFT Team

Sonia Cendejas

Operations Mgrs

Execute

Community level

Do:

Say:

Own:

MGRs

RXMs

Pharmacy Team

Theranos Phlebotomists

Operations Mgrs

Execute

Store level

Do:

Say:

Own:

IT

Finance

Call Center

Marketing

Theranos IT

Theranos Call Center

Support

Company, Program, and

Field levels

Do:

Say:

Own:

Trial Exh. 1884 Page 0038

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

22

Visuals: Table with five header cells and seven body rows. Header row (blue #56A0D3, white Calibri Bold): 'Key Stakeholders like…' spanning the first two columns, 'whose role is to…', '…the Vision at the…', 'Should do/say/own'. Row 1: stakeholders Brad Wasson, Rick Gates, Jeff Koziel, Nimesh Jhaveri | Elizabeth Holmes, Sunny Balwani | Define | Company level | Do:/Say:/Own:. Row 2: Nimesh Jhaveri, Casey Kozlowski, Mahesh Raju | Sunny Balwani, Tracy Masson, Joe Ahdoot, Christian Holmes | Define | Program/ Partnership level | Do:/Say:/Own:. Row 3: Matt Sesto, Brian Sizemore, Casey Kozlowski, Mahesh Raju | Tracy Masson, Kim Alfonso, Joe Ahdoot | Translate and reinforce | Kickoff Market level | Do:/Say:/Own:. Row 4: DMs, RXSs | Sonia Cendejas, Operations Mgrs, Theranos Sales | Translate and reinforce | District level | Do:/Say:/Own:. Row 5: CLs, TIFT Team | Sonia Cendejas, Operations Mgrs | Execute | Community level | Do:/Say:/Own:. Row 6: MGRs, RXMs, Pharmacy Team | Theranos Phlebotomists, Operations Mgrs | Execute | Store level | Do:/Say:/Own:. Row 7: IT, Finance, Call Center, Marketing | Theranos IT, Theranos Call Center | Support | Company, Program, and Field levels | Do:/Say:/Own:. Body rows alternate between #D0DFEE and #E9EFF7 fills with thin white gridlines. No photographs, charts or icons; the red logo mark at bottom left is the only graphic besides the blue band.

Slide 23

An Example: CLs, whose role is to execute the vision of a Superior Patient Experience; support the / Partnership Collaboration and drive Pharmacy Transformation at the Community and Store Level, / should… / Key Stakeholders like… / whose role is to… / …the Vision at the… / Should do/say/own / CLs / MGRs / RXMs / Pharmacy Team / Theranos Phlebotomists / Execute / Store level / Do: / Say: / Own: / CLs, whose role in Theranos is to execute the vision of a Superior Patient Experience and support the Partnership Collaboration at the Community and Store Level, should… / DO: / • Communicate about Theranos services and their benefits in the stores where it is offered; ask team members what they think about the service [Patient Experience, Partnership Collaboration] / • Ensure all the stores in your community are aware of Theranos services and where they are offered [Patient Experience, Partnership Collaboration] / • Regularly update and energize team members - celebrate positive patient experience results in your community [Patient Experience] / • Hold Store Managers in your community accountable for their store-level responsibilities; understand those responsibilities and ask about them on your Store Walks [Partnership Collaboration] / SAY: / • Have you gotten your lipid profile through Theranos yet? What did you think of the service? [Partnership Collaboration] / • (When in non-Theranos stores) Did you see what we are doing over in Store 1234? We can do lab testing services through our Pharmacy there now. Check out this booklet about the service. [Partnership Collaboration] / • I just wanted to recognize the great patient experience Jane provided to one of our Theranos patients. Listen to this great patient feedback! Great job Jane. [Patient Experience] / • John, it looks like there may have been some challenges last week with the bathrooms and having enough Theranos techs during peak time. What do we need to plan for in the next few weeks on scheduling, with immunizations coming up? [Patient Experience, Partnership Collaboration] / OWN: / • Their store’s and community’s Theranos Patient Experience results / • Accountability of their store’s Pharmacy Manager, and of their community’s Store Managers (for pharmacy scheduling, training, store and pharmacy team member engagement and experience) / • Maintain/increase the excitement around the incredible patient experience / Trial Exh. 1884 Page 0039 / ©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only. / 23

Visuals: Table with five body cells and four header cells. Header row (blue cells, white bold Calibri): 'Key Stakeholders like…' spanning columns x 2.2% to 32.2%; 'whose role is to…' x 32.2% to 47.2%; '…the Vision at the…' x 47.2% to 61.2%; 'Should do/say/own' x 61.2% to 98.2%. Body row (light blue cells, black Calibri): x 2.2% to 17.2% 'CLs' (bold), 'MGRs', 'RXMs', 'Pharmacy Team'; x 17.2% to 32.2% 'Theranos Phlebotomists'; x 32.2% to 47.2% 'Execute'; x 47.2% to 61.2% 'Store level'; x 61.2% to 98.2% 'Do:', 'Say:', 'Own:' (bold labels with no entries after them). Logos at lower left, 183 by 38 pixels: a red speech-bubble icon with a white stylised 'w' (Walgreens) followed by an orange-yellow chevron mark and the grey word CHANGE MANAGEMENT in capitals. No photographs, charts or diagrams.

Slide 24

Change Management Updates / Action Planning Exercise Results / Key Anchors Discussion / Readout from Discussion / Next Steps / Execute Against Change Management Action Planning Exercise Results / Leveraging Key Anchors and Action Planning Exercise Results, Finalize FY15 Change / Strategy Draft / Socialize FY15 Change Strategy / Trial Exh. 1884 Page 0040 / ©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only. / 24

Slide 25

W

Diagnostic Testing – Theranos Partnership Program

Measures of Success (SMART Goals)

August 6, 2014

Walgreens

AT THE CORNER OF HAPPY & HEALTHY™

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

Trial Exh. 1884 Page 0041

Visuals: Two logos and no photographs or charts. (1) Walgreens W mark: a red (#E4002B) speech-bubble-like square with a white cursive script 'W' and a small 'TM' mark at its lower right, with a dark red (#9B1B26) triangular fold/tail hanging from the lower-left corner. (2) Walgreens corporate logo at bottom right: red (#E31837) script wordmark 'Walgreens' above the tagline 'AT THE CORNER OF' in dark grey (#4D4D4D) capitals, followed by 'HAPPY' in green (#7AC143) and 'HEALTHY' in blue (#5BA3D6) capitals, '&' in dark grey, and a 'TM' superscript at the end of the tagline. No other visual elements.

Slide 26

SMART Program Measures for Success

SMART goals are defined as:

Specific: target a specific area for improvement

Measurable: quantify or at least suggest an indicator of progress

Achievable: realistic and attainable

Realistic: state what results can realistically be achieved, given available resources

Time-related: specify when the result(s) can be achieved

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

Trial Exh. 1884 Page 0042

26

Visuals: Logo: the red Walgreens 'W' logo (script 'w' in white inside a red rounded speech-bubble shape with a pointed lower-left tail) at bottom left, about 3.6% wide by 5.0% high, placed at x 6.1%, y 93.3%. No photographs, charts, or diagrams.

Slide 27

SMART Program Measures for Success / Category / Goal / Success Criteria / Owner(s) / Operational / Achieve acceptable labor model / 20 stores with Walgreens / Casey Kozlowski / employed phlebotomist/health / guide by 3/31/15 / Achieve and maintain a training pass rate of / Training pass rate =>90% / 90% by 8/31/15 / Patient Experience / Likelihood to come back by 8/31/15 / =>90% / Referral by friend or family member by / =>20% / 8/31/15 / Capture rate of 47% benchmark / =>47% benchmark / Conversion of non-Walgreens patients to / 10% of the 47% benchmark / become Walgreens patients / ©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only. / Trial Exh. 1884 Page 0043 / 27

Visuals: A table with four columns (Category, Goal, Success Criteria, Owner(s)) and a header row, followed by body rows. Row 1: Category 'Operational'; Goal 'Achieve acceptable labor model'; Success Criteria '20 stores with Walgreens employed phlebotomist/health guide by 3/31/15'; Owner 'Casey Kozlowski'. Row 2: Category blank; Goal 'Achieve and maintain a training pass rate of 90% by 8/31/15'; Success Criteria 'Training pass rate =>90%'; Owner blank. Row 3: Category 'Patient Experience'; Goal 'Likelihood to come back by 8/31/15'; Success Criteria '=>90%'; Owner blank. Row 4: Category blank; Goal 'Referral by friend or family member by 8/31/15'; Success Criteria '=>20%'; Owner blank. Row 5: Category blank; Goal 'Capture rate of 47% benchmark'; Success Criteria '=>47% benchmark'; Owner blank. Row 6: Category blank; Goal 'Conversion of non-Walgreens patients to become Walgreens patients'; Success Criteria '10% of the 47% benchmark'; Owner blank. Header cells are filled #56A0D3 with white bold Calibri; body rows alternate #D0DFEE and #E9EFF7 with white cell gutters between cells. Also a small Walgreens logo at bottom-left: a red speech-bubble shape with a white stylised 'w' mark, about 6% wide.

Slide 28

SMART Program Measures for Success, cont’d

Category

Goal

Success Criteria

Owner(s)

IT

Theranos PSC application uptime =>99%

Note: applicable to DSL connected stores only

Payor and

Providers

Payor coverage of at least 66%

Payor coverage of at least 66%

Financial

Achieve 15* patients/store/day for a store

that has been open at least 3 months by

8/31/15

Achieve 15 patients/store/day

HCC

% of lab orders driven from HCC

This is not being driven due to

steerage

Sunny Balwani/

Pat Carroll

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

Trial Exh. 1884 Page 0044

28

Visuals: A table with four columns (Category, Goal, Success Criteria, Owner(s)) and a header row plus four body rows. Header row, bold white Calibri on #56A0D3: Category | Goal | Success Criteria | Owner(s). Row 1: IT | Theranos PSC application uptime =>99% / Note: applicable to DSL connected stores only | (blank) | (blank). Row 2: Payor and Providers | Payor coverage of at least 66% | Payor coverage of at least 66% | (blank). Row 3: Financial | Achieve 15* patients/store/day for a store that has been open at least 3 months by 8/31/15 | Achieve 15 patients/store/day | (blank). Row 4: HCC | % of lab orders driven from HCC | This is not being driven due to steerage | Sunny Balwani/ Pat Carroll. Body rows alternate #D0DFEE and #E9EFF7 with white gutters between cells. The only other graphic is the small red Walgreens speech-bubble logo at bottom left.

Slide 29

Potential Measurable Success Metrics For Stores / Category / Goal / Success Criteria / Owner(s) / Training / % of eligible team members certified to perform / check in / 100% / % of eligible team members certified to perform / 90% / Must work more than 20 hours per week / Must be able to perform service using both hands / Religious reasons / Medical reasons / Position code is: / Perform: RxM, HG, Rx Tech / Check-In Only: SFL, ASMT, ASM, MGR / Action Item: / Need to work with ER to define eligible reasons / % of eligible team members certified to perform finger sticks / ©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only. / Trial Exh. 1884 Page 0045

Visuals: A four-column table with header cells Category, Goal, Success Criteria and Owner(s), all in bold white Calibri on medium blue. Row 1 (light blue fill): Category 'Training'; Goal '% of eligible team members certified to perform check in'; Success Criteria '100%'; Owner(s) blank. Row 2 (pale blue-grey fill): Category blank; Goal '% of eligible team members certified to perform finger sticks'; Success Criteria '90%' followed by a bullet list: 'Must work more than 20 hours per week', 'Must be able to perform service using both hands', 'Religious reasons', 'Medical reasons', 'Position code is:' with two sub-bullets 'Perform: RxM, HG, Rx Tech' and 'Check-In Only: SFL, ASMT, ASM, MGR', then bold 'Action Item:' with bullet 'Need to work with ER to define eligible reasons'; Owner(s) blank. Also a small Walgreens logo at bottom left: a red rounded speech-bubble shape with a white script 'W' and a small red tail at the lower left, 46 by 36 pixels, shown at about 3.6% by 5.0% of the slide.

Slide 30

Potential Measurable Success Metrics For Stores, cntd.

Category

Goal

Success Criteria

Owner(s)

Patient Experience

Patient check in time < X minutes

< 3 minutes

Patient wait + perform time < X minutes

< 7 minutes (between check in end and collection completion)

Survey scores > X

Average star rating per store and by tech

Average % 5 star ratings for 90% of Theranos services

Reduce people who will never come back

95% = yes

Number of sticks needed vs. ideal

>80%

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

Trial Exh. 1884 Page 0046

Visuals: A table with four columns and six rows including the header. Header row (Category | Goal | Success Criteria | Owner(s)) on #56A0D3 with white bold Calibri text. Row 1: Category 'Patient Experience'; Goal 'Patient check in time < X minutes'; Success Criteria '< 3 minutes'; Owner(s) blank. Row 2: Category blank; Goal 'Patient wait + perform time < X minutes'; Success Criteria '< 7 minutes (between check in end and collection completion)'; Owner(s) blank. Row 3: Category blank; Goal 'Survey scores > X'; Success Criteria bulleted list: 'Average star rating per store and by tech' and 'Average % 5 star ratings for 90% of Theranos services'; Owner(s) blank. Row 4: Category blank; Goal 'Reduce people who will never come back'; Success Criteria '95% = yes'; Owner(s) blank. Row 5: Category blank; Goal 'Number of sticks needed vs. ideal'; Success Criteria '>80%'; Owner(s) blank. The only other visual is the small red Walgreens logo at bottom left: a red speech-bubble shape with a white stylised 'W' script mark and a dark red tail at the lower left.

Slide 31

Potential Measurable Success Metrics For Stores, cntd.

Category

Goal

Success Criteria

Owner(s)

Patient (non-experience)

Patient volume

Measurement of here’s where / you’re at and here’s where you / are trending

% Venous Draws

<=10% venous draws by 8/31/15

Sunny Balwani

Net New vs. Existing Patients

Note: Need patient name and / zip code (confirm with analytics)

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

Trial Exh. 1884 Page 0047

Visuals: A table with four columns headed Category, Goal, Success Criteria and Owner(s). Header row: solid blue #56A0D3 cells with white bold Calibri text, centred. Row 1: Category 'Patient (non-experience)', Goal 'Patient volume', Success Criteria 'Measurement of here’s where you’re at and here’s where you are trending', Owner(s) blank. Row 2: Category blank, Goal '% Venous Draws', Success Criteria '<=10% venous draws by 8/31/15', Owner(s) 'Sunny Balwani'. Row 3: Category blank, Goal 'Net New vs. Existing Patients', Success Criteria 'Note: Need patient name and zip code (confirm with analytics)', Owner(s) blank. Body cell fills alternate: rows 1 and 3 light blue #D0DFEE, row 2 pale #E9EFF7; cells separated by thin white gridlines. Also a small Walgreens logo at bottom left: red #D71F26 speech-bubble shape with a white stylised 'W' script mark.

Slide 32

Diagnostic Testing – Theranos Partnership

Plan for FY15

August 6, 2014

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

Trial Exh. 1884 Page 0048

At the corner of HAPPY & HEALTHY™

Visuals: Logo: red Walgreens 'W' mark in a red speech-tab shape with a dark red folded corner tail pointing down-left, with a small TM mark at its right edge. Logo: Walgreens wordmark in red script with the tagline 'AT THE CORNER OF HAPPY & HEALTHY' in grey capitals, with HAPPY in green and HEALTHY in blue, and a TM mark. Background frame: a light blue (#5BA3D4) border surrounds a white panel with rounded corners of about 2% radius. No photographs, charts or diagrams.

Slide 33

Plan for FY15 / • Next market is Northern CA (5 stores initially, then expand for a total of 40) / • Expansion beyond the 5 stores will require Theranos data to obtain store selection / • Next markets? / • IL? IN? TX? FL? / • Plan for FY15 is to follow the Well Experience rollout as much as possible. / • Keeps build-out costs low / • WE personnel are often a good fit for Theranos services. / • Initial goal for FY15 (Sept-Aug) was 500 stores. Need to redefine this goal. / ©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only. / Trial Exh. 1884 Page 0049 / 33

Visuals: Walgreens logo (red speech-bubble shape with white script 'w' letter) at bottom-left, about 46 by 36 pixels, sitting at x 6.1%, y 93.3%, size 3.6% by 5.0%. No charts, photographs or other illustrations.

Slide 34

Diagnostic Testing – Theranos Partnership

California Plans

August 6, 2014

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

Trial Exh. 1884 Page 0050

Visuals: Walgreens W logo: a red (#E31837) rounded speech-bubble shape with a darker red (#9E1B24) folded tail at its lower left, with a white script 'W' cut into it and a small TM mark at its upper right. Walgreens tagline logo at bottom right: red script wordmark 'Walgreens' (#E31837) above the line 'AT THE CORNER OF HAPPY & HEALTHY™' in grey capitals (#6D6E71) with 'HAPPY' in green (#8DC63F) and 'HEALTHY' in blue (#5BA3D4). Background frame: a blue (#5BA3D4) full-bleed border with a white rounded-corner panel (corner radius about 3% of slide height) inset about 2.5% from the left and right edges and about 5% from the top and bottom. No photographs, charts or tables.

Slide 35

Theranos California Wave 1: T Minus Schedule

Timing

Target Date

Training event

T-10

8/6

• Finalize California Wave 1 store selection for 4 stores

T-9

8/11-8/22

• Conduct Field Webinars

8/11-8/15

• Assess store readiness and start construction process

T-8

8/11-9/12

• Hire Bots/HG

9/15-10/3

• Complete Bot/HG Training

T-5

9/8-9/26

• Conduct Check-In Training for existing WAG Techs

T-2

9/29-10/3

• Store Manager and Pharmacy Manager expectations/reminder/”coming very soon” Compass communications to stores in the Wave

9/29-10/10

(with copy to DM and RXS)

• TIFT Checklist for Pre-Launch Activities

T-1

10/13-10/17

• Reminder to DMs, RXSs, and CLs in districts/communities with stores going live in the wave: cascade or otherwise communicate to

all stores in your area about new capability in additional stores coming online in one week.

• 5 Minute Meeting scripts to all stores in wave, with instructions on using on or near go-live.

T

(Go Live)

10/21

• MVP recognition via email communications about latest wave of stores going live. Recognition of MGRs, RXMs, Pharmacists, Techs,

and other field personnel involved in stores launching successfully.

• Theranos Go-Live in 4 stores

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

Trial Exh. 1884 Page 0051

35

Visuals: Table with three columns and seven data rows, plus header row. Header: Timing | Target Date | Training event. Rows: T-10 | 8/6 | Finalize California Wave 1 store selection for 4 stores. T-9 | 8/11-8/22 and 8/11-8/15 | Conduct Field Webinars; Assess store readiness and start construction process. T-8 | 8/11-9/12 and 9/15-10/3 | Hire Bots/HG; Complete Bot/HG Training. T-5 | 9/8-9/26 | Conduct Check-In Training for existing WAG Techs. T-2 | 9/29-10/3 and 9/29-10/10 | Store Manager and Pharmacy Manager expectations/reminder/”coming very soon” Compass communications to stores in the Wave (with copy to DM and RXS); TIFT Checklist for Pre-Launch Activities. T-1 | 10/13-10/17 | Reminder to DMs, RXSs, and CLs in districts/communities with stores going live in the wave: cascade or otherwise communicate to all stores in your area about new capability in additional stores coming online in one week; 5 Minute Meeting scripts to all stores in wave, with instructions on using on or near go-live. T (Go Live) | 10/21 | MVP recognition via email communications about latest wave of stores going live. Recognition of MGRs, RXMs, Pharmacists, Techs, and other field personnel involved in stores launching successfully; Theranos Go-Live in 4 stores. Row bands alternate: teal tint on T-10, T-8, T-2 and T (Go Live) rows, white on T-9, T-5 and T-1 rows. Logo: Walgreens mark, a red speech-bubble shape with a white script 'w' in the centre, bottom left, about 3.6% wide.

Slide 36

California Theranos Rollout Timeline

2014

July

Aug

Sept

Oct

Store Selection

July 28:

Align on 4

candidate stores

Aug 6:

Finalize 4 locations

w/ Theranos & MP&R

Site Selection

Construction

Assess Store Readiness

Aug 11

Aug 15

Aug 11:

Finalize Design

Elements on D1

Aug 11

Design Elements

Oct 3

Aug 18

Permits

Aug 29

Perform Personnel

Sept 2

Perform Construction

Sept 30

Aug 11

Hiring WAG Personnel

Sept 12

Aug 11

State Regulations (HG & BOP)

Sept 12

Check-In Training

Aug 25

WAG Rx Staff, DH, & MGR

Sept 26

Perform Training

Sept 15

WAG Bot/HG

Oct 3

Sept 8

Check-In & Collection

Training

Sept 26

Communications

Aug 12

Field Webinar

Sept 23

Launch Readiness

Go Live

Oct 21

Trial Exh. 1884 Page 0052

©2014 Walgreen Co. All rights reserved. Confidential and proprietary information. For internal use only.

36

Visuals: Gantt-style timeline diagram with no axis chart. Top bar: a rounded grey (#6A737B) band labelled July, Aug, Sept, Oct in white bold Calibri, spanning x 13.4 to 77.0 percent. Left column: six small pennant arrow shapes pointing right, one per phase: Store Selection teal #75C7B9, Construction purple #B890C2, Perform Personnel grey #6A737B, Check-In Training blue #56A0D3, Perform Training green #7AC143, Communications pink #F07285. Bars with text inside: Site Selection (teal #75C7B9, white label, with two white triangle milestones at about 32 and 40.5 percent x, labelled July 28 and Aug 6); Assess Store Readiness (small purple bar, dates Aug 11 and Aug 15 on either side); Design Elements (purple #B890C2 bar, Aug 11 to Oct 3, with a white triangle milestone at its left end labelled Aug 11: Finalize Design Elements on D1); Permits (purple, Aug 18 to Aug 29); Perform Construction (purple, Sept 2 to Sept 30); Hiring WAG Personnel (orange #FC9D3A, Aug 11 to Sept 12); State Regulations (HG & BOP) (grey #6A737B, Aug 11 to Sept 12); WAG Rx Staff, DH, & MGR (blue #56A0D3, Aug 25 to Sept 26); WAG Bot/HG (green #7AC143, Sept 15 to Oct 3); Check-In & Collection Training (green #7AC143, Sept 8 to Sept 26); Communications bar (pink #F07285, spanning most of the width, with white triangle milestones labelled Aug 12 Field Webinar and Sept 23 Launch Readiness). Red star (#FF0000) at right, containing white bold text Go Live Oct 21, overlapping the right ends of the Perform Construction and Hiring areas. Light grey watermark text 'Confidential – Dates / Subject to Change' in the upper right. Walgreens logo: red speech-bubble shape with a white script 'w', at lower left, 46 by 36 pixels.

Slides 37 to 39 continue in the full text file.

Download this deck

The hosted PDF of every library deck is free for readers of the SlideDeck Co newsletter. Join with your email and the viewer and download appear here.

Preparing a results presentation or business update of your own? The SlideDeck Co Standard Deck is a slide library for business reviews, updates and plans.

More Reporting decks

Deck reviews in your inbox.

See what works in real company decks, what we’d change, and get the latest SDC releases.

Expanded slide preview